Skip to main content

Table 1 Baseline demographic data of septic patients treated or not treated with intravenous ascorbic acid

From: Phase I safety trial of intravenous ascorbic acid in patients with severe sepsis

Treatment

Gender

Age

APACHE II scorea

SOFA scoreb

Placebo

4 male 4 female

54 – 68 years

20.4 (15 – 29)

13.3 ± 2.9

Lo-AscA

5 male 3 female

30 – 70 years

20.4 (12 – 23)

10.1 ± 2.0

Hi-AscA

4 male 4 female

49 – 92 years

24.0 (12 – 33)

10.8 ± 4.4

  1. a APACHE Acute Physiology and Chronic Health Evaluation, mean (range).
  2. b SOFA Sequential Organ Failure Assessment, mean ± SE.